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Virulence markers to distinguish high from low virulence bovine viral diarrhea virus genotype 2 isolates have not been
previously reported. The objective of this study was to identify virulence markers by evaluating the primary and secondary
structures of the 59-untranslated region of low and high virulence bovine viral diarrhea virus genotype 2 isolates. The
nucleotide sequences of the entire 59-untranslated region mRNA of eight bovine viral diarrhea virus genotype 2 isolates, four
of high virulence and four of low virulence, and two genotype 1 reference isolates were determined using a polymerase chain
reaction and a 59 Rapid Amplification of cDNA Ends System. Two nucleotide substitutions were identified in the internal
ribosomal entry site that distinguished the high virulence from the low virulence genotype 2 isolates. The low virulence
isolates had a cytosine at position 219, whereas the high virulence isolates had a uracil. At position 278, a uracil or cytosine
was found in the low and high virulence groups, respectively. The substituted bases are virulence markers that were used
to identify bovine viral diarrhea virus genotype 2 isolates of high virulence. © 1998 Academic Press
INTRODUCTION
Bovine viral diarrhea virus (BVDV) is an economically
important pathogen that affects cattle worldwide. BVDV
can cause subclinical, peracute, acute, or chronic infec-
tions depending on the viral strain, degree of host im-
munity, and environmental stressors. Infection can cause
immunosuppression with an increased susceptibility to
secondary pathogens. It also causes abortions, terato-
genic effects, persistent infections, mucosal disease,
hemorrhagic syndrome, and death (Corapi et al., 1989,
1990; Liebler et al., 1995; McClurkin et al., 1984; Olafson
et al., 1946; Radostits and Littlejohns, 1988). BVDV is a
member of the genus Pestivirus within the Flaviviridae
(Francki et al., 1991). The viral genome is a 12.5-kb,
single-stranded, positive-polarity RNA that can be di-
vided into three regions: a 59-untranslated region (UTR)
containing an internal ribosomal entry site (IRES), a sin-
gle large open reading frame encoding a single polypro-
tein, and a 39-UTR. The genome lacks a 39 polyadenyl-
ated tail and appears to lack a 59 methylated cap struc-
ture (Brock et al., 1992; Collett, 1992; Collett et al., 1988a,
1988b, 1991; DeMoerlooze et al., 1993; Deng and Brock,
1992; Donis, 1995; Renard et al., 1985). Isolates of BVDV
can be separated into two biotypes, noncytopathic and
cytopathic, based on their effects in cell monolayers (Lee
and Gillespie, 1957). Isolates can be further divided into
two genotypes, BVDV1 and BVDV2, based on phyloge-
netic analysis of the 59-UTR (Pellerin et al., 1994; Ridpath
et al., 1994). A wide range of virulence exists among the
isolates within each genotype; however, virulence mark-
ers for BVDV have not been previously reported.
The 59-UTR of BVDV is highly conserved among all mem-
bers within the genus Pestivirus, yet sequence analysis of
the 59-UTR can readily distinguish BVDV1 isolates from
BVDV2 isolates. Secondary structural analysis of the 59-
UTR of BVDV has divided the region into four domains, A–D,
with domain D encompassing the 39 two thirds of the UTR
predicted to fold into a complex stem-loop structure, remi-
niscent of the complex structure formed by the IRES of
poliovirus (Brown et al., 1992; Deng and Brock, 1993; Hara-
sawa, 1994). Domain D is the most conserved region of the
59-UTR among pestiviruses examined. The apparent lack of
a 59 methylated cap structure in the BVDV genome and the
finding of an IRES in hepatitis C virus, a member of another
genus within the Flaviviridae, support the idea of this com-
plex secondary structure within the 59-UTR of BVDV being
the functional analog of the poliovirus IRES. Additionally,
uncapped transcripts of BVDV are infectious; therefore,
BVDV must initiate translation by a cap-independent mech-
anism similar to that initiated by the poliovirus IRES
(Meyers et al., 1996; Vassilev et al., 1997).
The genetic structure of picornaviruses, especially po-
liovirus, is similar to that of the pestiviruses. The 59-UTR
of poliovirus RNA is highly conserved among different
strains, in terms of both primary and secondary struc-
ture. Translation initiation occurs via a cap-independent
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mechanism associated with the IRES in the 59-UTR.
Markers of virulence have been mapped to single bases
within the picornavirus IRES. We hypothesized that viru-
lence markers for BVDV may be located within domain D,
which corresponds to the IRES of the 59-UTR.
In this study, we determined the 59-UTR mRNA se-
quence of two BVDV1 and eight BVDV2 isolates, four of
low virulence and four of high virulence. The four low
virulence isolates were recovered from four independent
herds in Nebraska, whereas the four high virulence iso-
lates were recovered from different herds in Iowa, Ne-
braska, and New York. The 59-UTR nucleotide sequences
were compared among the 10 BVDV isolates, as well as
with previously published BVDV sequences (Collett et al.,
1988b; DeMoerlooze et al., 1993; Deng and Brock, 1992;
Ridpath and Bolin, 1995). The sequence comparison
readily separated the BVDV1 isolates from the BVDV2
isolates. The BVDV2 isolates could further be divided into
high and low virulence groups based on the presence of
two single base substitutions located at positions 219
and 278 in domain D of the 59-UTR (Fig. 1). At position
219, the low virulence isolates had a cytosine and the
high virulence groups had a uracil, while at position 278
the reverse was observed with a cytosine in the high
virulence group and a uracil in the low virulence group.
Secondary structural analysis positioned the base sub-
stitution at position 219 within a loop and the other base
substitution at position 278 within a stem of the IRES.
The occurrences of these distinctive base differences
between the low virulence and the high virulence BVDV2
isolates readily identified BVDV2 isolates of high viru-
lence.
RESULTS AND DISCUSSION
Nucleotide sequence analysis
Using the 59 Rapid Amplification of cDNA Ends (RACE)
system and gene-specific primers that encompassed the
entire 59-UTR of BVDV, we amplified, cloned, and se-
quenced the cDNA of two BVDV1 reference isolates and
eight BVDV2 isolates of low or high virulence. The prim-
ers used for reverse transcription (RT)-polymerase chain
reaction (PCR) amplification and the use of the 59 RACE
system provided overlapping regions that allowed se-
quence analysis of the entire 59-UTR. The nucleotide
sequences of all 10 isolates were compared with the
published sequences of BVDV1 isolates NADL, SD-1, and
Osloss and BVDV2 isolate 890 (Fig. 2). Sequence num-
bers used throughout the present report refer to se-
quence alignment with the BVDV1–Osloss isolate, with
nucleotide 1 corresponding to the first base. The num-
bering of primers corresponds to the published se-
quence of BVDV1–NADL. Two nucleotide substitutions
were identified that distinguished the high virulence
BVDV2 isolates from the low virulence BVDV2 isolates.
These substitutions were located at positions 219 and
278 in domain D of the 59-UTR, which corresponds to the
IRES. At position 219, the low virulence BVDV2 isolates
had a cytosine, whereas the high virulence isolates had
a uracil. At position 278, the bases were uracil or cyto-
sine for the low and high virulence groups, respectively.
Comparison of domain D of the 59-UTR with the locations
of the base substitutions identified within our BVDV2
isolates places base 219 at the very beginning or within
a distal loop on a stem structure, whereas base 278 is
situated within a stem on domain D. These two specific
nucleotide substitutions are thus positioned within the
predicted IRES element of BVDV.
Picornaviruses have an overall genetic structure
similar to that of BVDV, including a 59-UTR involved in
cap-independent translation that has been well char-
acterized. Based on functional and structural charac-
teristics, the 59-UTR can be considered a tripartite
element. The 59 terminal 88 nucleotides of poliovirus
type 1 59-UTR are predicted to fold into a cloverleaf
structure, required for positive strand RNA synthesis
during viral multiplication (Andino et al., 1990, 1993).
Following this cloverleaf region is a highly structured
element referred to as the IRES, which allows ribo-
somes to enter the RNA without scanning from the 59
end (Jang et al., 1988, 1989; Pelletier and Sonenberg,
1988). The 39 end of the 59-UTR of ;150 nucleotides
can be deleted with little or no effect on virus growth
(Kuge and Nomoto, 1987; Pilipenko et al., 1992). The
FIG. 1. Schematic representation of the secondary structure of the
59-UTR of BVDV1 isolate SD-1 adapted from Deng and Brock (1993).
Domains A–D are indicated. The locations of virulence markers 219 and
278 are shown within domain D.
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FIG. 2. Sequence alignment of the 59-UTR of four low virulence (17011, 7937, 713, 5521) and four high virulence (890, NY93, 17583, 23025) BVDV2
isolates and two BVDV1 (NADL and NY1) reference isolates with published BVDV1 sequences, Osloss and SD-1 (Bolin and Ridpath, 1992; Collett et
al., 1988b; DeMoerlooze et al., 1993; Deng and Brock, 1992; Marshall et al., 1996; Odeo´n et al., 1997 (unpublished data); Ridpath and Bolin, 1995).
Numbering of the sequences is based on the sequence of the BVDV1-Osloss isolate, with nucleotide number 1 corresponding to the first base of the
Osloss isolate. The base substitutions at positions 219 and 278 that differentiate low and high virulence BVDV2 isolates are marked with arrows (2).
Potential initiation condons are indicated in bold lettering. (p) Published sequences. (.) Identical bases to BVDV1-Osloss isolate. (-) Gaps.
166 TOPLIFF AND KELLING
59-UTR of poliovirus has been divided into seven do-
mains, A–G (Haller et al., 1993; Pelletier and Sonen-
berg, 1988). The stem-loops found in domains D–G are
involved in the formation of the IRES element within
the 59-UTR.
Genomic determinants of virulence have been de-
scribed for members of the Picornaviridae, including
poliovirus (Evans et al., 1985; Kawamura et al., 1989; Ren
et al., 1991). By evaluating vaccine strains of poliovirus
and their revertant neurovirulent counterparts, as well as
using site-directed mutagenesis and infectious clones,
several determinants of virulence for poliovirus have
been localized to areas within the 59-UTR, especially to
the IRES. The primary and secondary structures of the
genomic 59-UTR are involved in the neurovirulence of the
virus. Single nucleotide substitutions within the poliovi-
rus IRES are capable of attenuating neurovirulent strains.
Attenuating mutations are associated with an alteration
of the secondary structure of the IRES, creating a less
stable configuration in avirulent strain versus virulent
strains (Bienkowska-Szewczyk and Ehrenfeld, 1988; Bou-
chard et al., 1995; Evans et al., 1985; Gromeier
et al., 1996; Haller et al., 1993; Iizuka et al., 1989;
Kawamura et al., 1989; Kuge and Nomoto, 1987; Li et al.,
1996; Lu et al., 1996; McGoldrick et al., 1995; Macadam et
al., 1991, 1992, 1993; Minor and Dunn, 1988; Racaniello
and Meriam, 1986; Ren et al., 1991; Skinner et al., 1989;
Svitkin et al., 1985). Kawamura et al. (1989) determined
that a nucleotide substitution at position 480 of the po-
liovirus type 1 strain, from a guanine to an adenine,
resulted in the attenuated virus being converted to a
neurovirulent form. Ren et al. (1991) found that an ade-
nine at nucleotide 481 in the 59-UTR and an isoleucine at
position 143 of VP1 were major determinants of attenu-
ation in the poliovirus P2/P712 strain, an attenuated virus
closely related to the type 2 Sabin vaccine strain. Evans
et al. (1985) showed that a substitution of a uracil for a
cytosine at position 472 of poliovirus type 3 was selected
for by passage through the gastrointestinal tract and was
associated with a demonstrable increase in the neuro-
virulence of the virus. These single nucleotide substitu-
tions in the different poliovirus strains are located within
the IRES element of the 59-UTR. The role of the 59-UTR in
virulence has also been demonstrated for other picorna-
viruses (Duke et al., 1990; Stein et al., 1992). Thus, our
findings of two specific base substitutions that correlate
with virulence are presumed to be biologically significant
because of their location within the IRES.
The nucleic acid identities among the BVDV1 isolates
ranged from 86.8% to 100%, with our NADL isolate se-
quence having 100% homology with the published NADL
(Collett et al., 1988b). The identities among the BVDV2
isolates ranged from 92.5% to 99.7% (Table 1). Our 890
isolate had a 99.7% homology with the published 890
(Ridpath and Bolin, 1995). A single nucleotide difference
was found at position 132, with our 890 isolate having an
adenine and that of the previously published 890 having
a cytosine. Between genotypes, the homology ranged
from 75.2% to 79.7%, clearly illustrating the higher degree
of sequence homology within a genotype than between
genotypes. The 59-UTR of the 10 isolates ranged in
length from 381 to 387 nucleotides. The 59-UTR of BVDV1
NY-1 was the shortest with 381 bases, while the 59-UTR
of BVDV2 7937 was the longest with 387 bases. The UTR
of BVDV2 isolates 5521, 17011, and 17583–97 each had
386 bases, whereas the UTR of the remaining five iso-
lates had 385 bases each. Further analysis of the 59-
UTRs showed 36 polymorphic bases distributed through-
out the 59-UTR differentiated isolates into either geno-
type 1 or 2. These base substitutions were conserved
TABLE 1
Nucleotide Sequence Identity
Pub.
BVDV1-
NADL
Pub.
BVDV1-
Osloss
Pub.
BVDV1-
SD-1
Pub.
BVDV2-
890
BVDV1-
NADL
BVDV1-
NY1
BVDV2-
NY93
BVDV2-
17583
BVDV2-
23025
BVDV2-
890
BVDV2-
713
BVDV2-
5521-95
BVDV2-
17011-96
BVDV2-7937 77.2 76.9 76.7 94.5 77.2 78.4 95.1 95.6 95.8 94.8 94.3 95.1 95.1
BVDV2-17011-96 79.3 76.3 79.3 92.5 79.3 79.7 93.5 94.0 94.3 92.7 95.1 96.4
BVDV2-5521-95 78.5 75.2 77.4 93.2 78.5 77.6 94.5 94.5 94.8 93.5 96.1
BVDV2-713 76.4 76.0 76.6 92.5 76.4 78.4 93.2 93.2 93.5 92.7
BVDV2-890 76.6 75.5 75.6 99.7 76.6 76.8 95.8 95.8 96.1
BVDV2-23025 78.5 77.0 76.6 95.8 78.5 78.9 98.7 99.7
BVDV2-17583 78.0 76.6 76.2 95.6 78.0 78.4 98.4
BVDV2-NY93 78.0 76.5 76.6 95.6 78.0 78.6
BVDV1-NY1 90.3 91.6 86.8 76.5 90.3
BVDV1-NADL 100 89.5 93.2 76.4
Pub.BVDV2-890 76.4 75.2 75.3
Pub.BVDV1-SD-1 93.2 87.4
Pub.BVDV1-Osloss 89.5
Note. Identity given in %.
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within the genotype. Three of the nucleotide substitu-
tions at positions 202, 243, and 322 were localized in
AUG codons that are conserved within the genotype 2
isolates and were not found in the BVDV1 isolates. The
significance of the different lengths of the 59-UTRs and
the 36-base differences between genotypes is unclear
but may influence the secondary structure and the ter-
tiary interactions of the 59-UTR, affecting the function and
efficiency of the IRES element.
Examination of the sequences of two BVDV1 reference
isolates and the eight BVDV2 isolates, as well as pub-
lished sequences, revealed 5–12 potential initiation
codons preceding the authentic initiation codon. The
BVDV2 isolates consistently had more initiation codons
ranging from 8 to 12, whereas the BVDV1 isolates had
only 5 or 6. The function of these codons is unknown.
Pelletier et al. (1988) examined the upstream AUG
codons of poliovirus type 2 Lansing strain by creating
point mutations in each of the seven AUG codons pre-
ceding the authentic initiation codon. They found that
none of the upstream codons were essential for viral
replication, and the codons did not act as barriers for
mRNA translation. Mutation of AUG 7 decreased the
translational efficiency compared with the wild-type virus
but did not inhibit viral replication. They concluded that
AUG 7 may play a positive role in poliovirus RNA trans-
lation. A similar situation may exist in the BVDV 59-UTR,
but further investigations are necessary to test this hy-
pothesis.
Computer-predicted secondary structural analysis of
the 59-UTR of the isolates in our study gave a potential
structure for each isolate. The structures were variable
among the isolates, but a common feature was the lo-
cation of the two base substitutions that correlate with
virulence: base 219 was located within a loop (Fig. 3A),
and base 278 was located within a stem (Fig. 3B) of a
highly structured element corresponding to the IRES of
the 59-UTR. Examination of the nucleotide base substi-
tutions 472, 480, and 481 of poliovirus with the predicted
secondary structures of poliovirus type 3 and ECHO virus
type 25 JV4 positions each of the bases within a stem or
a loop of the 59-UTR IRES element (Bailly et al., 1996;
Evans et al., 1985; Skinner et al., 1989). This further
supports our conclusion that bases 219 and 278 are
virulence markers of these BVDV2 isolates.
Enzyme immunoassay
BVDV isolates were genotyped based on the reactivity
patterns to monoclonal antibodies (MAbs) using an im-
munoperoxidase staining procedure. Results of the en-
zyme immunoassay are shown in Table 2. MAb 15C5
directed against BVDV gp48, MAbs 1–11 directed against
BVDV gp53, and MAb 8G12 directed against bovine re-
FIG. 3. Secondary structure of loop and stem elements of the IRES
showing the location of each base substitution that differentiates
high from low virulence BVDV2 isolates. (A) Base 219 located within
a loop structure of the IRES. (B) Base 278 located within a stem
element of the IRES.
TABLE 2
Enzyme Immunoassay Results
Binding
buffer 15C5 MAb 1 MAb 2 MAb 3 MAb 4 MAb 5 MAb 6 MAb 7 MAb 8 MAb 9 MAb 10 MAb 11 8G12
Uninfected NVSL BT 2a 2 2 2 2 2 2 2 2 2 2 2 2 2
NVSL BT lysate 2 2 2 2 2 2 2 2 2 2 2 2 2 2
BVDV1-NADL 2 1b 1 1 1 1 2 2 1 1 1 2 2 2
BVDV1-NY1 2 1 1 2 2 2 2 2 1 2 2 2 2 2
BVDV2-890 2 1 1 2 2 2 2 2 2 2 2 2 2 2
BVDV2-23025 2 1 1 2 2 2 2 2 2 2 2 2 2 2
BVDV2-17583 2 1 1 2 2 2 2 2 2 2 2 2 2 2
BVDV2-NY93 2 1 1 2 2 2 2 2 2 2 2 1 2 2
BVDV2-7937 2 1 1 2 2 2 2 2 2 2 2 2 2 2
BVDV2-17011-96 2 1 1 2 2 2 2 2 2 2 2 2 2 2
BVDV2-5521-95 2 1 1 2 2 2 2 2 2 2 2 2 2 2
BVDV2-713 2 1 1 2 2 2 2 2 2 2 2 2 2 2
BRSV 375 2 2 2 2 2 2 2 2 2 2 2 2 2 1
a,b Reactions were of equal intensity and designated (1) for positive and (2) for negative.
168 TOPLIFF AND KELLING
spiratory syncytial virus (BRSV) F protein were used in
the immunoassay. Reactions were of equal intensity and
designated (1) for positive and (2) for negative. MAb
15C5 and MAb 1 reacted strongly with the two BVDV1
and eight BVDV2 isolates evaluated. BVDV1-NADL re-
acted with several MAbs, including 1–4 and 7–9. NY-1
also reacted with MAb 7. BVDV2-NY93 reacted with MAb
10. MAb 8G12 was included as a control and only re-
acted with cells infected with BRSV. The MAb reactivity
pattern showed the genotype identity of the BVDV iso-
lates as BVDV1 for NADl and NY1 and BVDV2 for 890,
NY93, 23025, 17583, 7937, 17011, 713, and 5521.
Phylogeny
The relatedness of the BVDV nucleotide sequences
were analyzed using the GCG program PILEUP, which
clustered the multiple sequence alignments of the
published and experimental BVDV sequences based
on their similarities (Fig. 4). Both the sequence align-
ment of the 59-UTR and the dendogram clearly sepa-
rate the BVDV1 from the BVDV2 isolates. Within the
BVDV2 cluster, the high virulence isolates branch from
a common point, illustrating their relatedness. The low
virulence BVDV2 isolates fell into two cluster relation-
ships, with 713 and 5521 appearing to be more closely
related to the high virulence group than to the other
two low virulence isolates.
MATERIALS AND METHODS
Cells, viruses and monoclonal antibodies
Bovine turbinate (BT) cells originated from the National
Veterinary Services Laboratory, United States Depart-
ment of Agriculture (Ames, IA). Cells were grown as
monolayers in Dulbecco’s modified Eagle’s medium sup-
plemented with 10% equine serum in a 37°C humidified
incubator with 5% CO2. Twelve MAbs directed against
BVDV glycoproteins were used to determine the geno-
type of the BVDV isolates using a MAb reactivity pattern
in an enzyme immunoassay. The viral isolates consisted
of eight noncytopathic BVDV2, one noncytopathic BVDV1,
and one cytopathic BVDV1. Approximately 104 BT cells/
well of 96-well tissue culture plates were inoculated with
virus at an m.o.i. of 1. BRSV was used as an irrelevant
control virus, and noninfected BT cells and BT cells
inoculated with control cell lysate were used as negative
controls. Cells were incubated at 37°C in a humidified
chamber with 5% CO2. Cytopathic viruses (BRSV and
BVDV1-NADL) were incubated for 38 h, and the remain-
ing noncytopathic BVDV isolates were incubated for 5
days. The cells were fixed with 20% acetone–phosphate-
buffered saline for 10 min and then allowed to dry over-
night at room temperature. MAb 15C5 specific for BVDV
gp48 (Dr. E. Dubovi, Cornell University), 8G12 specific for
BRSV F protein (Klucas and Anderson, 1988), and MAbs
1–11 specific for BVDV gp53 (Corapi et al., 1988; Donis et
al., 1988) were used as the primary antibodies, and
biotinylated horse anti-mouse immunoglobulin antibod-
ies (Vector Laboratories) were used as the secondary
antibody. Streptavidin-horseradish peroxidase complex
and AEC were used to complete the immunoperoxidase
procedure. All staining was done in triplicate.
The BVDV2 isolates were assigned to either the low or
high virulence group based on the severity of clinical
presentation of disease in experimentally infected calves
or the animals from which they originated (Table 3). The
high virulence BVDV2 isolates 890, NY-93, 23025–93, and
17583–97 were isolated from tissues of cattle affected
with peracute, fatal BVDV infections in Iowa (890), New
York (NY-93), or Nebraska (23025–93 and 17583–97).
Calves experimentally infected with NY-93 (Odeo´n et al.,
1997; unpublished data) or 890 (Bolin and Ridpath, 1992)
developed severe disease and exhibited high body tem-
perature, lymphopenia, and hemorrhagic enteritis. The
low virulence BVDV2 isolates included 7937, 713–2,
5521–95, and 17011–96. The latter three isolates were
derived from fetuses aborted from cows with transient,
FIG. 4. Dendogram representing the relatedness of the BVDV1 and
BVDV2 59-UTR nucleotide sequences. The dendogram clearly sepa-
rates the BVDV1 from the BVDV2 isolates. The high virulence isolates
branch from a common point illustrating their relatedness. (H) High
virulence. (L) Low virulence. *Published sequences (Collett et al.,
1988b; DeMoerlooze et al., 1993; Deng and Brock, 1992).
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nonfatal, acute BVDV infections in three independent
Nebraska herds. Isolate 7937 was isolated from a per-
sistently infected calf from a vaccinated Nebraska herd
(Kelling et al., 1990). Experimental infection of calves with
7937 caused only mild, transient, acute disease (Mar-
shall et al., 1996). The BVDV1 isolates were prototype
reference strains noncytopathic NY-1 and cytopathic
NADL, obtained from NVSL. Each noncytopathic isolate
was biologically cloned before use through three suc-
cessive cell culture passages at limiting dilutions and
amplified by cell culture until a TCID50 of 10
5 or greater
was achieved. The cytopathic NADL isolate was biolog-
ically cloned by plaque picking. BT cell culture passages
were from 29 to 37 and were inoculated with BVDV at an
m.o.i. of 1 and incubated at 37°C in 5% CO2. Control and
virus-infected cell lysates were prepared by a single
freeze-thaw of mock- or virus-inoculated BT cells and
stored at 280°C.
Preparation of total RNA
Total RNA was extracted from control and virus-in-
fected cell lysate using TRIZOL LS Reagent (GIBCO BRL,
Grand Island, NY) according to the manufacturer’s direc-
tions. Extracted RNA was stored in 75% ethanol at either
220°C or 280°C. Before use, the extracted total RNA
was pelleted and resuspended in 10 ml of diethylpyro-
carbonate-treated water/ml of viral cell lysate extracted.
cDNA synthesis, PCR amplification, and cloning
The 59 end of viral genome. RT, cDNA synthesis, and
DNA amplifications were done using the 59 RACE sys-
tem, Version 2.0 (GIBCO BRL), according to the manu-
facturer’s directions. Briefly, cDNA synthesis was done
using Superscript II reverse transcriptase (GIBCO BRL)
and primer 6 (59-TTTGTATCTAGATCATTTGTGATAACTCCA-39)
complementary to the sequence NADL strain nucleo-
tides 387–406, with an XbaI restriction site incorporated
six bases from the 59 end (underlined). After digestion of
the RNA from the RNA–DNA duplexes with RNase mix,
the cDNA was separated from RT byproducts by Glass-
Max DNA isolation spin cartridges (GIBCO BRL). A ho-
mopolymeric tail of cytosine bases was added to the 39
end of the cDNA using terminal deoxynucleotidyl trans-
ferase and dCTP. PCR amplification of the tailed cDNA
was performed with Taq polymerase for 35 cycles using
the 59 RACE abridged anchor primer (59-GGCCACGC-
GTCGACTAGTACGGGIIGGGIIGGGIIG-39) and a modi-
fied gene-specific primer 2 (59-GCCATGTACAGCAGAGAT-39),
which was complementary to NADL nucleotides 366–
383 (Ridpath et al., 1993). The PCR working profiles were
as follows: 94°C for 1 min to denature the DNA, 53°C for
1 min to allow primer annealing, and 72°C for 2 min to
allow primer extension. PCR-amplified products (5 ml)
were diluted in TE buffer (495 ml) and used for nested
PCR. Nested PCR primers were the universal amplifica-
tion primer (59-CUACUACUACUAGGCCACGCGTCGAC-
TAGTAC-39) and a modified gene-specific primer 3 (59-
CAUCAUCAUCAUCGAACCACTGACGACTAC-39), which
was complementary to NADL nucleotides 188–205 (Rid-
path et al., 1993). Primers for the nested PCR contained
the uracil DNA glycosylase (UDG) cloning region (under-
lined) for subsequent cloning into the pAMP1 vector. The
PCR working profile was the same as above with the
exception of 63°C as the primer annealing temperature.
All gene-specific primers were purchased from Genosys
(Woodlands, TX). PCRs for each isolate were done in
triplicate to correct for inherent base misincorporation
due to Taq polymerase.
The 59-UTR between nucleotide 30 and the authentic
AUG codon. Downstream primer 6 and upstream primer 5
(59-ATGTAGGTACCAATTAGAAAAGGCACTCGTAT-39), which
corresponds to NADL nucleotides 10–30 and has a KpnI
restriction site (underlined) incorporated four bases from
the 59 end, were used for RT-PCR. The PCR working
profile included 10 cycles of 94°C for 1 min, 45°C for 1
min, and 72°C for 2 min. This was followed by 30 cycles
of 94°C for 1 min, 59°C for 1 min, and 72°C for 2 min.
Again, the reactions were done in triplicate.
PCR products were analyzed on a 1.25% agarose gel
in 0.53 TBE. Bands of an appropriate size were ex-
cised from the gel using the Qiaex II Gel Extraction Kit
(Qiagen, Chatsworth, CA) according to the manufac-
turer’s directions.
Gel-extracted PCR products were cloned into pAMP1
plasmid (GIBCO BRL) or pCR2.1 plasmid (InVitrogen, San
Diego, CA) and used to transform competent Escherichia
coli strains DH5a and TOP10F9, respectively. Colonies
were selected and expanded, and the plasmid DNA
purified using Wizard Plus Minipreps DNA Purification
System (Promega, Madison, WI). Plasmid DNA was an-
TABLE 3
Characteristics of the BVDV Isolates
Isolate Genotype Biotype
Clinical Presentation, State,
and Date of Origin
NADL 1 Cytopathic Prototypea
NY1 1 Noncytopathic Prototypea
890 2 Noncytopathic Hemorrhagic syndrome, IA,a 1990
23025 2 Noncytopathic Hemorrhagic syndrome, NE,b 1993
NY93 2 Noncytopathic Acute BVD, NY,c 1993
17583 2 Noncytopathic Acute BVD, NE,b 1997
17011 2 Noncytopathic Fetal abortion, NE,b 1996
713 2 Noncytopathic Fetal abortion, NE,b 1982
5521 2 Noncytopathic Fetal abortion, NE,b 1995
7937 2 Noncytopathic Persistent infection, NE,b 1988
a National Veterinary Services Laboratory, United States Department
of Agriculture, Ames, IA.
b Veterinary Diagnostic Center, Department of Veterinary and Bio-
medical Sciences, University of Nebraska, Lincoln, NE.
c Dr. E. Dubovi, Cornell University, Ithaca, NY.
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alyzed using restriction endonuclease digestion to verify
the identify of the cloned insert.
Sequencing of cDNA clones and computer analysis
The nucleotide sequence of the inserts from one clone
derived from each of three independent PCR–ligation–
transformations was determined for both strands of plas-
mid DNA insert using dideoxy cycle sequencing. The
products were analyzed on an Applied Biosystems
model 377 automated DNA sequencer (DNA Sequencing
Facility, Iowa State University, Ames, IA). Nucleotide se-
quences were assembled and analyzed using the
PILEUP and GAP programs of the GCG Software pack-
age (Version 9, Genetics Computer Group, Madison, WI).
The secondary structure predictions were created with
the programs RNAFOLD and SQUIGGLES.
Nucleotide accession numbers
The nucleotide sequence data reported here have
been assigned the following accession numbers from
GenBank: AF039172 for isolate 23025, AF039173 for iso-
late NY93, AF039174 for isolate 5521–95, AF039175 for
isolate 7937, AF039176 for isolate 17583–97, AF039177 for
isolate 713–2, AF039178 for isolate NY1, AF039179 for
isolate 17011–96, AF039180 for isolate 890, and
AF039181 for isolate NADL.
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